DMII Drugs Made In America Acquisition II Corp. Ordinary Shares
Financial Services$10.06+0.00%OpenMarket Cap: $528.3M
As of 2026-05-26
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
0.01
P/S
0.00
EV/EBITDA
-4.62
DCF Value
—
FCF Yield
-13.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
2.3%
ROA
1.7%
ROIC
-0.3%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 null | $0.00 | $4.3M | $— |
| Q4 null | $0.00 | $4.3M | $— |
| FY null | $0.00 | $4.2M | $— |
| Q3 null | $0.00 | $-46.2K | $— |
Trading Activity
Insider Trades
View AllDo Catherinedirector
SellFri Oct 17
Shulgan Myron W.director
SellThu Oct 02
Worman Glenn C.officer: CFO
SellWed Oct 01
Company Info
Sector
Financial Services
Industry
Shell Companies
Country
US
Exchange
—
Beta
0.04
Drugs Made In America Acquisition II Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2024 and is based in Fort Lauderdale, Florida.